source
- Eli Lilly makes 14th acquisition of 2026, buying a blood-cancer biotechEli Lilly announced it has acquired a blood‑cancer focused biotechnology company, marking its 14th acquisition in 2026. The deal reflects Lilly’s aggressive expansion strategy, funded by strong sa…
- Addiction Society Issues First Guidance on Managing Medetomidine WithdrawalThe American Society of Addiction Medicine (ASAM) has published its first national guidance for clinicians on how to identify and treat patients experiencing withdrawal from medetomidine, a sedativ…